Dermal Fillers
RADIESSE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 11053
·
GTIN 4046222005146
Radiesse (+) Lidocaine
Radiesse (+) Lidocaine is an injectable filler designed to smooth facial wrinkles and folds. It is used for temporary correction of lower-face volume loss and to improve jawline contour.
In stock
Volume
1 x 1,5 mL
Laboratory
Merz Aesthetics
Origin
Germany
Indication
Moderate to deep facial folds, facial volume loss
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Radiesse (+) Lidocaine is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics. Its principal component is synthetic calcium hydroxylapatite (CaHA) with a particle size of 25 to 45 microns, suspended in a gel carrier of sterile water for injection, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride, buffered with sodium phosphate salts. By volume the implant is 30% CaHA particles and 70% gel carrier. The lidocaine provides a short-term local anaesthetic effect during administration.
The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection, giving a long-term but non-permanent restoration and augmentation. It is intended for deep dermal and sub-dermal soft tissue augmentation and is administered with a 27G needle.
Supplied as one pre-filled 1.5 mL syringe with two 27G thin-wall needles, sterile in a sealed foil pouch, for single person and single treatment use. ALLPARA supplies Radiesse (+) Lidocaine to clinics and licensed practitioners on a business-to-business basis, with batch-level traceability and documentation available to registered professional buyers on request.
Key Benefits of Radiesse (+) Lidocaine
- Synthetic calcium hydroxylapatite implant with 0.3% lidocaine hydrochloride included for a short-term local anaesthetic effect during injection
- 30% CaHA particles and 70% gel carrier by volume, with a particle size of 25 to 45 microns
- The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the CaHA remains at the injection site
- Indicated for the jawline and marionette lines in addition to nasolabial folds, cheeks and the dorsum of the hands
- A lifetime of at least 12 months for cheek augmentation, the jawline and hand augmentation, as demonstrated minimums rather than expected end points
- Well suited to supraperiosteal, sub-dermal and deep dermal placement; jawline placement by blunt-tip cannula has been clinically evaluated
- Supplied sterile in a sealed foil pouch as one 1.5 mL syringe with two 27G thin-wall needles
- CE marked under EU MDR 2017/745 via notified body 0123, supplied with a patient Implant Card
- Manufactured by Merz Aesthetics in Germany, with batch-level traceability on every unit supplied by ALLPARA
Indications and Professional Use
Main indications
- Treatment of nasolabial folds
- Augmentation of the cheeks
- Treatment of marionette lines
- Treatment of the jawline
- Hand augmentation to correct volume loss in the dorsum of the hands
Professional use
Radiesse (+) Lidocaine is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law. The product is supplied sterile and non-pyrogenic in a sealed foil pouch and is intended for single-person, single-treatment use only, for deep dermal and sub-dermal soft tissue augmentation. Because this presentation contains 0.3% lidocaine hydrochloride, practitioners must screen for known hypersensitivity to lidocaine or to anaesthetics of the amide type before use. Injection technique, plane and volume are determined by the treating practitioner on a per-patient basis. Introduction of the implant into the vasculature may lead to embolisation, occlusion of the vessels, ischaemia or infarction, so particular care is required when injecting soft tissue fillers. The product must not be re-sterilised, and must not be used if the foil pouch is compromised or the syringe damaged.
Treatment areas
- Nasolabial folds
- Cheeks
- Marionette lines
- Jawline
- Dorsum of the hands
- Not intended for the glabellar folds or the nose area, where a higher incidence of localised necrosis has been associated with injection
Patient profile
Suitable for adult patients assessed as appropriate by the treating practitioner. Radiesse (+) Lidocaine is contraindicated in the presence of acute or chronic inflammation or infection involving the area to be treated; in persons with severe allergies manifested by a history of anaphylaxis, or a history or presence of multiple severe allergies; in persons with known hypersensitivity to any of the components; in persons with known hypersensitivity to lidocaine or to anaesthetics of the amide type; in persons prone to developing inflammatory skin conditions or with a tendency to develop hypertrophic scars and keloids; and during pregnancy and in breastfeeding females. It must not be implanted in the epidermis or used as a skin replacement, and is not intended for correction of the glabellar folds or the nose area. For hand augmentation, the safety of injection into the dorsum of the hand has not been studied in persons under 26 or over 79 years of age, volumes over 3 mL per hand in a treatment session have not been studied, and safety beyond two years in the hand has not been investigated in clinical trials.
How Radiesse (+) Lidocaine Works
Radiesse (+) Lidocaine works through synthetic calcium hydroxylapatite microspheres, 25 to 45 microns in size, suspended in a gel carrier of sterile water, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride. The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection, producing a long-term yet non-permanent restoration and augmentation.
Highly viscoelastic CaHA is well suited to supraperiosteal, sub-dermal and deep dermal placement, where it delivers a considerable volumising effect. The lidocaine acts locally during administration to provide a short-term anaesthetic effect and does not alter this action.
Why Order From Allpara
Allpara offers genuine, verified RADIESSE products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does Radiesse (+) Lidocaine differ from standard Radiesse?
Radiesse (+) Lidocaine contains 0.3% lidocaine hydrochloride in the gel carrier, which provides a short-term local anaesthetic effect during administration. The indications also differ: this presentation covers marionette lines and the jawline in addition to nasolabial folds, cheeks and the dorsum of the hands.
Which areas is Radiesse (+) Lidocaine indicated for?
It is indicated for the treatment of nasolabial folds, augmentation of the cheeks, treatment of marionette lines, treatment of the jawline, and hand augmentation to correct volume loss in the dorsum of the hands. It is not intended for the glabellar folds or the nose area.
How long does Radiesse (+) Lidocaine last?
It has a lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6 to 7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points.
What is supplied in the pack?
Each syringe unit with needle convenience pack consists of one pre-filled syringe containing 1.5 mL of Radiesse (+) Lidocaine and a Terumo K-Pack II with two 27G thin-wall injection needles. The product is supplied sterile and non-pyrogenic in a sealed foil pouch and is for single person, single treatment use.
How do clinics order Radiesse (+) Lidocaine wholesale?
ALLPARA supplies Radiesse (+) Lidocaine to clinics and licensed practitioners on a B2B account. Stock status, expiry dates and batch documentation are provided to registered professional buyers on request.
More from Merz
BELOTERO references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
BELOTERO Products
View all 7
Clinic alternatives
/ Recently viewed
Pick up where you left off
Radiesse (+) Lidocaine
In stock
CE Marked
Radiesse (+) Lidocaine is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics. Its principal component is synthetic calcium hydroxylapatite (CaHA) with a particle size of 25 to 45 microns, suspended in a gel carrier of sterile water for injection, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride, buffered with sodium phosphate salts. By volume the implant is 30% CaHA particles and 70% gel carrier. The lidocaine provides a short-term local anaesthetic effect during administration.
The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection, giving a long-term but non-permanent restoration and augmentation. It is intended for deep dermal and sub-dermal soft tissue augmentation and is administered with a 27G needle.
Supplied as one pre-filled 1.5 mL syringe with two 27G thin-wall needles, sterile in a sealed foil pouch, for single person and single treatment use. ALLPARA supplies Radiesse (+) Lidocaine to clinics and licensed practitioners on a business-to-business basis, with batch-level traceability and documentation available to registered professional buyers on request.
Key Benefits of Radiesse (+) Lidocaine
- Synthetic calcium hydroxylapatite implant with 0.3% lidocaine hydrochloride included for a short-term local anaesthetic effect during injection
- 30% CaHA particles and 70% gel carrier by volume, with a particle size of 25 to 45 microns
- The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the CaHA remains at the injection site
- Indicated for the jawline and marionette lines in addition to nasolabial folds, cheeks and the dorsum of the hands
- A lifetime of at least 12 months for cheek augmentation, the jawline and hand augmentation, as demonstrated minimums rather than expected end points
- Well suited to supraperiosteal, sub-dermal and deep dermal placement; jawline placement by blunt-tip cannula has been clinically evaluated
- Supplied sterile in a sealed foil pouch as one 1.5 mL syringe with two 27G thin-wall needles
- CE marked under EU MDR 2017/745 via notified body 0123, supplied with a patient Implant Card
- Manufactured by Merz Aesthetics in Germany, with batch-level traceability on every unit supplied by ALLPARA
Indications and Professional Use
Main indications
- Treatment of nasolabial folds
- Augmentation of the cheeks
- Treatment of marionette lines
- Treatment of the jawline
- Hand augmentation to correct volume loss in the dorsum of the hands
Professional use
Radiesse (+) Lidocaine is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law. The product is supplied sterile and non-pyrogenic in a sealed foil pouch and is intended for single-person, single-treatment use only, for deep dermal and sub-dermal soft tissue augmentation. Because this presentation contains 0.3% lidocaine hydrochloride, practitioners must screen for known hypersensitivity to lidocaine or to anaesthetics of the amide type before use. Injection technique, plane and volume are determined by the treating practitioner on a per-patient basis. Introduction of the implant into the vasculature may lead to embolisation, occlusion of the vessels, ischaemia or infarction, so particular care is required when injecting soft tissue fillers. The product must not be re-sterilised, and must not be used if the foil pouch is compromised or the syringe damaged.
Treatment areas
- Nasolabial folds
- Cheeks
- Marionette lines
- Jawline
- Dorsum of the hands
- Not intended for the glabellar folds or the nose area, where a higher incidence of localised necrosis has been associated with injection
Patient profile
Suitable for adult patients assessed as appropriate by the treating practitioner. Radiesse (+) Lidocaine is contraindicated in the presence of acute or chronic inflammation or infection involving the area to be treated; in persons with severe allergies manifested by a history of anaphylaxis, or a history or presence of multiple severe allergies; in persons with known hypersensitivity to any of the components; in persons with known hypersensitivity to lidocaine or to anaesthetics of the amide type; in persons prone to developing inflammatory skin conditions or with a tendency to develop hypertrophic scars and keloids; and during pregnancy and in breastfeeding females. It must not be implanted in the epidermis or used as a skin replacement, and is not intended for correction of the glabellar folds or the nose area. For hand augmentation, the safety of injection into the dorsum of the hand has not been studied in persons under 26 or over 79 years of age, volumes over 3 mL per hand in a treatment session have not been studied, and safety beyond two years in the hand has not been investigated in clinical trials.
How Radiesse (+) Lidocaine Works
Radiesse (+) Lidocaine works through synthetic calcium hydroxylapatite microspheres, 25 to 45 microns in size, suspended in a gel carrier of sterile water, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride. The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection, producing a long-term yet non-permanent restoration and augmentation.
Highly viscoelastic CaHA is well suited to supraperiosteal, sub-dermal and deep dermal placement, where it delivers a considerable volumising effect. The lidocaine acts locally during administration to provide a short-term anaesthetic effect and does not alter this action.
Why Order From Allpara
Allpara offers genuine, verified RADIESSE products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does Radiesse (+) Lidocaine differ from standard Radiesse?
Radiesse (+) Lidocaine contains 0.3% lidocaine hydrochloride in the gel carrier, which provides a short-term local anaesthetic effect during administration. The indications also differ: this presentation covers marionette lines and the jawline in addition to nasolabial folds, cheeks and the dorsum of the hands.
Which areas is Radiesse (+) Lidocaine indicated for?
It is indicated for the treatment of nasolabial folds, augmentation of the cheeks, treatment of marionette lines, treatment of the jawline, and hand augmentation to correct volume loss in the dorsum of the hands. It is not intended for the glabellar folds or the nose area.
How long does Radiesse (+) Lidocaine last?
It has a lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6 to 7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points.
What is supplied in the pack?
Each syringe unit with needle convenience pack consists of one pre-filled syringe containing 1.5 mL of Radiesse (+) Lidocaine and a Terumo K-Pack II with two 27G thin-wall injection needles. The product is supplied sterile and non-pyrogenic in a sealed foil pouch and is for single person, single treatment use.
How do clinics order Radiesse (+) Lidocaine wholesale?
ALLPARA supplies Radiesse (+) Lidocaine to clinics and licensed practitioners on a B2B account. Stock status, expiry dates and batch documentation are provided to registered professional buyers on request.
More from Merz
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.